Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Yadollah Omidi, Maha Mobasher, Ana M. Castejon & Morteza Mahmoudi. (2022) Recent advances in nanoscale targeted therapy of HER2-positive breast cancer. Journal of Drug Targeting 30:7, pages 687-708.
Read now
Read now
Maitham Alhajamee, Khadeeja Marai, Sameer Mohammed Naser Al Abbas & Masoud Homayouni Tabrizi. (2022) Co-encapsulation of curcumin and tamoxifen in lipid-chitosan hybrid nanoparticles for cancer therapy. Materials Technology 37:9, pages 1183-1194.
Read now
Read now
Ayimukedisi Yalikong, Xu-Quan Li, Ping-Hong Zhou, Zhi-Peng Qi, Bing Li, Shi-Lun Cai & Yun-Shi Zhong. (2021) A Triptolide Loaded HER2-Targeted Nano-Drug Delivery System Significantly Suppressed the Proliferation of HER2-Positive and BRAF Mutant Colon Cancer. International Journal of Nanomedicine 16, pages 2323-2335.
Read now
Read now
Articles from other publishers (29)
Meryem Osum & Rasime Kalkan. 2023.
Muneeb U. Rehman, Andleeb Khan, Zuha Imtiyaz, Shafat Ali, Hafiz Antar Makeen, Summya Rashid & Azher Arafah. (2022) Current nano-therapeutic approaches ameliorating inflammation in cancer progression. Seminars in Cancer Biology 86, pages 886-908.
Crossref
Crossref
Yan-Qi Zhao, Li-Jun Li, Er-Fen Zhou, Jiang-Yue Wang, Ying Wang, Lin-Miao Guo & Xin-Xin Zhang. (2022) Lipid-Based Nanocarrier Systems for Drug Delivery: Advances and Applications. Pharmaceutical Fronts 04:02, pages e43-e60.
Crossref
Crossref
Yining Xu, Thibaut Fourniols, Yasmine Labrak, Véronique Préat, Ana Beloqui & Anne des Rieux. (2022) Surface Modification of Lipid-Based Nanoparticles. ACS Nano 16:5, pages 7168-7196.
Crossref
Crossref
Guilherme F Picheth, Fernando A de O Ganzella, João OC Filizzola, Yan K Canquerino, Gabriela C Cardoso, Michelle B Collini, Leonardo B Colauto, Maria Cristina Figueroa-Magalhães, Edneia ASR Cavalieri & Giseli Klassen. (2022) Ligand-mediated nanomedicines against breast cancer: a review. Nanomedicine 17:9, pages 645-664.
Crossref
Crossref
Kumar Ganesan, Yan Wang, Fei Gao, Qingqing Liu, Chen Zhang, Peng Li, Jinming Zhang & Jianping Chen. (2021) Targeting Engineered Nanoparticles for Breast Cancer Therapy. Pharmaceutics 13:11, pages 1829.
Crossref
Crossref
Md Rizwanullah, Ahmad Perwez, Showkat Rasool Mir, Mohd Moshahid Alam Rizvi & Saima Amin. (2021) Exemestane encapsulated polymer-lipid hybrid nanoparticles for improved efficacy against breast cancer: optimization, in vitro characterization and cell culture studies. Nanotechnology 32:41, pages 415101.
Crossref
Crossref
Hui Wang, Hongyi Zhang, Yihao Zhu, Zhonghang Wu, Chunhong Cui & Fengfeng Cai. (2021) Anticancer Mechanisms of Salinomycin in Breast Cancer and Its Clinical Applications. Frontiers in Oncology 11.
Crossref
Crossref
Lucia Ruxandra Tefas, Cristina Barbălată, Cristian Tefas & Ioan Tomuță. (2021) Salinomycin-Based Drug Delivery Systems: Overcoming the Hurdles in Cancer Therapy. Pharmaceutics 13:8, pages 1120.
Crossref
Crossref
Yavuz Nuri Ertas, Keyvan Abedi Dorcheh, Ali Akbari & Esmaiel Jabbari. (2021) Nanoparticles for Targeted Drug Delivery to Cancer Stem Cells: A Review of Recent Advances. Nanomaterials 11:7, pages 1755.
Crossref
Crossref
Yong Zhuang, Yiye Zhao, Bingyue Wang, Qi Wang, Tiange Cai & Yu Cai. (2021) Strategies for Preparing Different Types of Lipid Polymer Hybrid Nanoparticles in Targeted Tumor Therapy. Current Pharmaceutical Design 27:19, pages 2274-2288.
Crossref
Crossref
Rakesh Kumar Dhritlahre & Ankit Saneja. (2021) Recent advances in HER2-targeted delivery for cancer therapy. Drug Discovery Today 26:5, pages 1319-1329.
Crossref
Crossref
Vrinda Gote, Anantha Ram Nookala, Pradeep Kumar Bolla & Dhananjay Pal. (2021) Drug Resistance in Metastatic Breast Cancer: Tumor Targeted Nanomedicine to the Rescue. International Journal of Molecular Sciences 22:9, pages 4673.
Crossref
Crossref
Hongxia Duan, Yanhong Liu, Zhonggao Gao & Wei Huang. (2021) Recent advances in drug delivery systems for targeting cancer stem cells. Acta Pharmaceutica Sinica B 11:1, pages 55-70.
Crossref
Crossref
Bessi Qorri, Alexandria DeCarlo, Matthew Mellon & Myron R. Szewczuk. 2021. Drug Delivery Devices and Therapeutic Systems. Drug Delivery Devices and Therapeutic Systems
423
454
.
Huseyin Beyaz, Hasan Uludag, Doga Kavaz & Nahit Rizaner. 2021. Cell Biology and Translational Medicine, Volume 14. Cell Biology and Translational Medicine, Volume 14
163
181
.
Abhinay Thakur, Rohit Sharma, Vivek Sheel Jaswal, Eugenie Nepovimova, Ashun Chaudhary & Kamil Kuca. (2020) Psoralen: A Biologically Important Coumarin with Emerging Applications. Mini-Reviews in Medicinal Chemistry 20:18, pages 1838-1845.
Crossref
Crossref
Azubuike Peter Ebokaiwe, Emmanuel Mfotie Njoya, Yuwen Sheng, Zhonghui Zhang, Sheng Li, Zongyuan Zhou, Zhe Qiang, Ting Peng, Ahmed A. Hussein, Guolin Zhang, Xiaoxia Lu, Lin Li & Fei Wang. (2020) Salinomycin promotes T-cell proliferation by inhibiting the expression and enzymatic activity of immunosuppressive indoleamine-2,3-dioxygenase in human breast cancer cells. Toxicology and Applied Pharmacology 404, pages 115203.
Crossref
Crossref
Vikas Jain, Hitesh Kumar, Haritha V. Anod, Pallavi Chand, N. Vishal Gupta, Surajit Dey & Siddharth S. Kesharwani. (2020) A review of nanotechnology-based approaches for breast cancer and triple-negative breast cancer. Journal of Controlled Release 326, pages 628-647.
Crossref
Crossref
Qi-Yao Wei, Yan-Ming Xu & Andy T. Y. Lau. (2020) Recent Progress of Nanocarrier-Based Therapy for Solid Malignancies. Cancers 12:10, pages 2783.
Crossref
Crossref
Ayeskanta Mohanty, Saji Uthaman & In-Kyu Park. (2020) Utilization of Polymer-Lipid Hybrid Nanoparticles for Targeted Anti-Cancer Therapy. Molecules 25:19, pages 4377.
Crossref
Crossref
Ranjit K. Harwansh, Shiv Bahadur, Rohitas Deshmukh & Md. A. Rahman. (2020) Exciting Potential of Nanoparticlized Lipidic System for Effective Treatment of Breast Cancer and Clinical Updates: A Translational Prospective. Current Pharmaceutical Design 26:11, pages 1191-1205.
Crossref
Crossref
Manish Kumar & P.S. Rajnikanth. (2020) A Mini-review on HER2 Positive Breast Cancer and its Metastasis: Resistance and Treatment Strategies. Current Nanomedicine 10:1, pages 36-47.
Crossref
Crossref
Ranjita Misra, Sangeetha Kandoi, Sudha Varadaraj, S. Vijayalakshmi, A. Nanda & Rama S. Verma. (2020) Nanotheranostics: A tactic for cancer stem cells prognosis and management. Journal of Drug Delivery Science and Technology 55, pages 101457.
Crossref
Crossref
Yu-Ling Lin, Nu-Man Tsai, Chia-Hung Chen, Yen-Ku Liu, Chung-Jen Lee, Yi-Lin Chan, Yu-Shan Wang, Yuan-Ching Chang, Chi-Hsin Lin, Tse-Hung Huang, Chao Ching Wang, Kwan-Hwa Chi & Kuang-Wen Liao. (2019) Specific drug delivery efficiently induced human breast tumor regression using a lipoplex by non-covalent association with anti-tumor antibodies. Journal of Nanobiotechnology 17:1.
Crossref
Crossref
Liuwei Zhang, Ming Qian, Jingyun Wang, Jing Xia, Hongyan Cui & Qixian Chen. (2019) Nitrophenyl-engaged photocleavage of an amphiphilic copolymer for spatiotemporally controlled drug release. Journal of Materials Science 54:20, pages 13298-13313.
Crossref
Crossref
Emma Polonio-Alcalá, Marc Rabionet, Santiago Ruiz-Martínez, Joaquim Ciurana & Teresa Puig. (2019) Three-Dimensional Manufactured Supports for Breast Cancer Stem Cell Population Characterization. Current Drug Targets 20:8, pages 839-851.
Crossref
Crossref
Manling Du, Yong Ouyang, Fansu Meng, Xingwang Zhang, Qianqian Ma, Yong Zhuang, Hui Liu, Mujuan Pang, Tiange Cai & Yu Cai. (2019) Polymer-lipid hybrid nanoparticles: A novel drug delivery system for enhancing the activity of Psoralen against breast cancer. International Journal of Pharmaceutics 561, pages 274-282.
Crossref
Crossref
Vivek Kaushik, Juan Yakisich, Anil Kumar, Neelam Azad & Anand Iyer. (2018) Ionophores: Potential Use as Anticancer Drugs and Chemosensitizers. Cancers 10:10, pages 360.
Crossref
Crossref